Skip to main content

Table 2 Selected studies of neoadjuvant chemoradiation.

From: Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO)

Study Institution

Number of patients

Total dose of XRT (Gy)

Chemo-therapy (mg/m2)

Median OS (months)

1(2,4,5)-year-OS-rate (%)

Rate local recurrence (%)

Rate of resectability (%)

Rate of clear resections

Hoffman et al. 1998[39, 40] multi-centric

53

50.4

5-FU/MMC

9.7 all pts

15.7 res

2y: 27 res

24/53 (26 %)

3/24 (13%) res

24/53 (45%)

n.a

Snady et al. 2000 [29]Mount Sinai

159

68* (20 res§)

91 adj

54 + 14 Gy

5-FU/cDDP/Streptozotocin

23.6* (32 res)

14.0

1 y: 86*(89)vs.64

2y: 58*(60) vs.32

3y: 27*(40)vs.17

n.a.

20/68 (29%)

-

95% neo

84% adj

Breslin et al. 2001 [20] MDACC

132

45 or 50.4 Gy

or 10 × 3 Gy ± IORT

5-FU, or Tax or Gem

21

1y: 75

2y: 40

5y: 23

8/132 (6%)

-

88%

Sasson AR et al.2003 [28]FCCC

116

61 neo

55 adj

50.4

5-FU/MMC or Gem

all 18

neo 23

adj 16

n.a.

n.a.

-

39%

n.a.

n.a.

White et al. 2005 [21]Duke

193

i.p.r.:102

i.l.f.: 91

45 + 5.4 Gy

5-FU or Gem

23

39 i.p.r.

20 i.l.f.

3y: 37 res

5y: 27 res

n.a.

70/193 (36%)

54/102 (53%)

16/91 (18%)

73%

n.a.

n.a.

  1. Abbreviations: 5-FU = 5-fluorouracil; adj = adjuvant therapy; cDDP = cisplatin; FCCC = Fox Chase Cancer Center, Philadelphia, PA; Gem = gemcitabine; Gy = Dose in Gray; i.p.r = initially potentially resectable; i.l.f. = initially locally advanced, MDACC = M.D. Anderson Cancer Center Houston, TX; MMC = mitomycin C; n.a. = not available; neo = neoadjuvant; OS = overall survival; res = resected patients, RT = radiotherapy; Tax = paclitaxel; vs. = versus. *initially unresectable patients ± resection after chemoradiation; § this study indicates overall survival as explained: (1) patients with chemoradiation (2) numbers in brackets: patients with chemoradiation and resection (3) right to 'vs.': patients after primary resection; § numbers in brackets in this row give results of the 20/68 resected patients with RCT.